Your browser doesn't support javascript.
loading
Benralizumab's anti-eosinophil efficacy may be decreased by impaired NK cell activity.
Poznanski, Sophie M; Portillo, Ana; Mukherjee, Manali; Bhalla, Anurag; Son, Kiho; Ashkar, Ali A; Khalidi, Nader; Nair, Parameswaran.
Afiliação
  • Poznanski SM; Division of Clinical Immunology and Allergy, McMaster University and St Joseph's Healthcare, Hamilton, ON, Canada.
  • Portillo A; Division of Clinical Immunology and Allergy, McMaster University and St Joseph's Healthcare, Hamilton, ON, Canada.
  • Mukherjee M; Division of Respirology, McMaster University and St Joseph's Healthcare, Hamilton, ON, Canada.
  • Bhalla A; Division of Respirology, McMaster University and St Joseph's Healthcare, Hamilton, ON, Canada.
  • Son K; Division of Respirology, McMaster University and St Joseph's Healthcare, Hamilton, ON, Canada.
  • Ashkar AA; Division of Clinical Immunology and Allergy, McMaster University and St Joseph's Healthcare, Hamilton, ON, Canada.
  • Khalidi N; Division of Rheumatology, McMaster University and St Joseph's Healthcare, Hamilton, ON, Canada.
  • Nair P; Division of Respirology, McMaster University and St Joseph's Healthcare, Hamilton, ON, Canada parames@mcmaster.ca.
Eur Respir J ; 59(4)2022 04.
Article em En | MEDLINE | ID: mdl-34887323
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Eosinófilos / Anticorpos Monoclonais Humanizados Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Eosinófilos / Anticorpos Monoclonais Humanizados Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article